Bard Associates’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,773
| Closed | -$44K | – | 162 |
|
|
2020
Q1 | $44K | Sell |
1,773
-3
| -0.2% | -$74 | 0.03% | 149 |
|
|
2019
Q4 | $87K | Sell |
1,776
-78
| -4% | -$3.82K | 0.04% | 151 |
|
|
2019
Q3 | $91K | Sell |
1,854
-83
| -4% | -$4.07K | 0.05% | 151 |
|
|
2019
Q2 | $176K | Sell |
1,937
-32
| -2% | -$2.91K | 0.09% | 141 |
|
|
2019
Q1 | $291K | Sell |
1,969
-35
| -2% | -$5.17K | 0.15% | 128 |
|
|
2018
Q4 | $316K | Sell |
2,004
-122
| -6% | -$19.2K | 0.18% | 123 |
|
|
2018
Q3 | $521K | Sell |
2,126
-43
| -2% | -$10.5K | 0.24% | 108 |
|
|
2018
Q2 | $486K | Sell |
2,169
-16
| -0.7% | -$3.59K | 0.23% | 117 |
|
|
2018
Q1 | $535K | Buy |
2,185
+27
| +1% | +$6.61K | 0.27% | 109 |
|
|
2017
Q4 | $665K | Sell |
2,158
-3
| -0.1% | -$924 | 0.32% | 104 |
|
|
2017
Q3 | $790K | Sell |
2,161
-25
| -1% | -$9.14K | 0.37% | 98 |
|
|
2017
Q2 | $796K | Hold |
2,186
| – | – | 0.36% | 101 |
|
|
2017
Q1 | $650K | Sell |
2,186
-43
| -2% | -$12.8K | 0.3% | 103 |
|
|
2016
Q4 | $491K | Sell |
2,229
-28
| -1% | -$6.17K | 0.23% | 110 |
|
|
2016
Q3 | $542K | Sell |
2,257
-14
| -0.6% | -$3.36K | 0.26% | 105 |
|
|
2016
Q2 | $445K | Sell |
2,271
-61
| -3% | -$12K | 0.24% | 110 |
|
|
2016
Q1 | $1M | Sell |
2,332
-11
| -0.5% | -$4.72K | 0.58% | 72 |
|
|
2015
Q4 | $885K | Sell |
2,343
-156
| -6% | -$58.9K | 0.52% | 72 |
|
|
2015
Q3 | $677K | Sell |
2,499
-24
| -1% | -$6.5K | 0.39% | 86 |
|
|
2015
Q2 | $742K | Sell |
2,523
-51
| -2% | -$15K | 0.37% | 85 |
|
|
2015
Q1 | $710K | Sell |
2,574
-21
| -0.8% | -$5.79K | 0.34% | 92 |
|
|
2014
Q4 | $1.12M | Buy |
2,595
+85
| +3% | +$36.7K | 0.52% | 75 |
|
|
2014
Q3 | $822K | Sell |
2,510
-5
| -0.2% | -$1.64K | 0.38% | 87 |
|
|
2014
Q2 | $847K | Buy |
2,515
+73
| +3% | +$24.6K | 0.34% | 104 |
|
|
2014
Q1 | $1.09M | Hold |
2,442
| – | – | 0.46% | 86 |
|
|
2013
Q4 | $1.09M | Buy |
+2,442
| New | +$1.09M | 0.46% | 80 |
|